Phraction Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-367
| Closed | -$233K | – | 81 |
|
|
2025
Q1 | $233K | Hold |
367
| – | – | 0.08% | 69 |
|
|
2024
Q4 | $261K | Hold |
367
| – | – | 0.09% | 63 |
|
|
2024
Q3 | $386K | Hold |
367
| – | – | 0.14% | 54 |
|
|
2024
Q2 | $386K | Hold |
367
| – | – | 0.14% | 51 |
|
|
2024
Q1 | $353K | Hold |
367
| – | – | 0.14% | 51 |
|
|
2023
Q4 | $322K | Hold |
367
| – | – | 0.13% | 46 |
|
|
2023
Q3 | $302K | Hold |
367
| – | – | 0.14% | 45 |
|
|
2023
Q2 | $264K | Sell |
367
-95
| -21% | -$68.3K | 0.13% | 43 |
|
|
2023
Q1 | $380K | Sell |
462
-90
| -16% | -$74K | 0.22% | 40 |
|
|
2022
Q4 | $398K | Hold |
552
| – | – | 0.26% | 35 |
|
|
2022
Q3 | $380K | Buy |
552
+50
| +10% | +$34.4K | 0.29% | 41 |
|
|
2022
Q2 | $297K | Buy |
+502
| New | +$297K | 0.2% | 56 |
|